|
| 36864784 | Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS. | | 2023 |
| 37760589 | Repurposing Clemastine to Target Glioblastoma Cell Stemness. | Cancers (Basel) | 2023 |
| 36639156 | Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. | J Immunother Cancer | 2023 |
| 37072349 | Intratumor childhood vaccine-specific CD4 T-cell recall coordinates antitumor CD8 T cells and eosinophils. | | 2023 |
| 36753564 | Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. | | 2023 |
| 37004712 | Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. | | 2023 |
| 35487217 | Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition. | Cancer Cell | 2022 |
| 36175036 | Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma. | Journal for ImmunoTherapy of Cancer | 2022 |
| 33767151 | Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling. | Nature Communications | 2021 |
| 33875611 | Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. | Journal for ImmunoTherapy of Cancer | 2021 |
| 31988324 | Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. | Nature Communications | 2020 |
| 31040154 | MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation. | Cancer Research | 2019 |
| 30500933 | MGMT: Immunohistochemical Detection in High-Grade Astrocytomas. | Journal of Neuropathology and Experimental Neurology | 2019 |
| 30346624 | Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas. | Neuro-Oncology | 2019 |
| 30625226 | Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. | PLoS ONE | 2019 |
| 31142380 | Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations. | Journal for ImmunoTherapy of Cancer | 2019 |
| 29802247 | The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma. | Nat Commun | 2018 |
| 30266879 | Correction: Reversing the Warburg effect as a treatment for glioblastoma. | Journal of Biological Chemistry | 2018 |
| 30120661 | Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status. | Journal of Neuro-Oncology | 2018 |
| 29878245 | Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma. | J Neuropathol Exp Neurol | 2018 |
| 29872344 | Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer. | Cancer Management and Research | 2018 |
| 30131529 | Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells. | Sci Rep | 2018 |
| 29943666 | Recurrent Glioblastoma Treated with Recombinant Poliovirus. | New England Journal of Medicine | 2018 |
| 29854587 | Application of mutagen sensitivity assay in a glioma case-control study. | Toxicology Reports | 2018 |
| 29097607 | Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1-Induced Metabolic Liabilities. | Cancer Research | 2018 |
| 29093005 | Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma. | Cancer Research | 2018 |
| 29564747 | Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. | Journal of Neuro-Oncology | 2018 |
| 29437767 | T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. | Clin Cancer Res | 2018 |
| 29703821 | A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. | Clinical Cancer Research | 2018 |
| 29115565 | AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival. | International Journal of Oncology | 2018 |
| 28024998 | Development and validation of a cell-based fluorescent method for measuring antibody affinity. | Journal of Immunological Methods | 2017 |
| 28379574 | The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival. | Neuro Oncol | 2017 |
| 28981720 | Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display. | Protein Engineering, Design and Selection | 2017 |
| 28939681 | Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation. | Cancer Research | 2017 |
| 28411277 | Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. | Clinical Cancer Research | 2017 |
| 28931654 | Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs. | Science Translational Medicine | 2017 |
| 28829151 | Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. | | 2017 |
| 29100338 | Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors. | Oncotarget | 2017 |
| 28013405 | Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial. | Applied Microbiology and Biotechnology | 2017 |
| 28229994 | Immunotoxin Therapy for Lung Cancer. | Chinese Medical Journal | 2017 |
| 28148827 | Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression. | Molecular Cancer Research | 2017 |
| 27806313 | Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models. | Oncotarget | 2016 |
| 26976201 | Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. | Lancet Oncol | 2016 |
| 27364552 | Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors. | Cancer Research | 2016 |
| 26728879 | Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats. | Investigational New Drugs | 2016 |
| 26822025 | CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. | Cancer Immunology Research | 2016 |
| 26766590 | MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. | Cancer Cell | 2016 |
| 27255663 | IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. | Sci Rep | 2016 |
| 28286803 | EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery. | | 2016 |
| 26061751 | Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. | N Engl J Med | 2015 |